These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 29743290)

  • 1. Cerebrospinal fluid immunoglobulin light chain ratios predict disease progression in multiple sclerosis.
    Rathbone E; Durant L; Kinsella J; Parker AR; Hassan-Smith G; Douglas MR; Curnow SJ
    J Neurol Neurosurg Psychiatry; 2018 Oct; 89(10):1044-1049. PubMed ID: 29743290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic and Prognostic Value of the Cerebrospinal Fluid Concentration of Immunoglobulin Free Light Chains in Clinically Isolated Syndrome with Conversion to Multiple Sclerosis.
    Makshakov G; Nazarov V; Kochetova O; Surkova E; Lapin S; Evdoshenko E
    PLoS One; 2015; 10(11):e0143375. PubMed ID: 26606531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of free light chains lambda and kappa in early multiple sclerosis.
    Voortman MM; Stojakovic T; Pirpamer L; Jehna M; Langkammer C; Scharnagl H; Reindl M; Ropele S; Seifert-Held T; Archelos JJ; Fuchs S; Enzinger C; Fazekas F; Khalil M
    Mult Scler; 2017 Oct; 23(11):1496-1505. PubMed ID: 27899552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concentrations of immunoglobulin free light chains in cerebrospinal fluid predict increased level of brain atrophy in multiple sclerosis.
    Nazarov V; Makshakov G; Kalinin I; Lapin S; Surkova E; Mikhailova L; Gilburd B; Skoromets A; Evdoshenko E
    Immunol Res; 2018 Dec; 66(6):761-767. PubMed ID: 30635824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cerebrospinal fluid free kappa light chains and kappa index perform equal to oligoclonal bands in the diagnosis of multiple sclerosis.
    Christiansen M; Gjelstrup MC; Stilund M; Christensen T; Petersen T; Jon Møller H
    Clin Chem Lab Med; 2018 Dec; 57(2):210-220. PubMed ID: 30055097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The association of intrathecal production of immunoglobulin free light chains and progression of multiple sclerosis].
    Makshakov GS; Nazarov VD; Totolyan NA; Lapin SV; Mazing AV; Emanuel VL; Krasnov VS; Shumilina MV; Skoromets AA; Evdoshenko EP
    Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(10. Vyp. 2):4-10. PubMed ID: 29359727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Free light chains in the cerebrospinal fluid. Comparison of different methods to determine intrathecal synthesis.
    Hegen H; Walde J; Milosavljevic D; Aboulenein-Djamshidian F; Senel M; Tumani H; Deisenhammer F; Presslauer S
    Clin Chem Lab Med; 2019 Sep; 57(10):1574-1586. PubMed ID: 31112501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebrospinal fluid B cells and disease progression in multiple sclerosis - A longitudinal prospective study.
    Wurth S; Kuenz B; Bsteh G; Ehling R; Di Pauli F; Hegen H; Auer M; Gredler V; Deisenhammer F; Reindl M; Berger T
    PLoS One; 2017; 12(8):e0182462. PubMed ID: 28777826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of cerebrospinal fluid kappa free light chains with the intrathecal polyspecific antiviral immune response in multiple sclerosis.
    Huss A; Mojib-Yezdani F; Bachhuber F; Fangerau T; Lewerenz J; Otto M; Tumani H; Senel M
    Clin Chim Acta; 2019 Nov; 498():148-153. PubMed ID: 31437445
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glial and neuroaxonal biomarkers in a multiple sclerosis (MS) cohort.
    Kalatha T; Hatzifilippou E; Arnaoutoglou M; Balogiannis S; Koutsouraki E
    Hell J Nucl Med; 2019; 22 Suppl 2():113-121. PubMed ID: 31802051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cerebrospinal fluid free light chains compared to oligoclonal bands as biomarkers in multiple sclerosis.
    Gaetani L; Di Carlo M; Brachelente G; Valletta F; Eusebi P; Mancini A; Gentili L; Borrelli A; Calabresi P; Sarchielli P; Ferri C; Villa A; Di Filippo M
    J Neuroimmunol; 2020 Feb; 339():577108. PubMed ID: 31743879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Free light chain monomer-dimer patterns in the diagnosis of multiple sclerosis.
    Kaplan B; Golderman S; Yahalom G; Yeskaraev R; Ziv T; Aizenbud BM; Sela BA; Livneh A
    J Immunol Methods; 2013 Apr; 390(1-2):74-80. PubMed ID: 23376556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple sclerosis progression in a natural history study: predictive value of cerebrospinal fluid free kappa light chains.
    Rudick RA; Medendorp SV; Namey M; Boyle S; Fischer J
    Mult Scler; 1995 Nov; 1(3):150-5. PubMed ID: 9345445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determination of sensitivities and specificities of cerebrospinal fluid free light chains to diagnose multiple sclerosis- a multicentric case-control study.
    Thevarkalam M; Krishnan S; Shanmughan LI; Mathai A; Leelamani JV; Kannoth S; Bhaskaran R; Iype T; Panda S
    Mult Scler Relat Disord; 2023 Jun; 74():104717. PubMed ID: 37062197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of cerebrospinal fluid biomarkers in multiple sclerosis: The key role of kappa free light chains and a multivariate predictor for disease progression.
    Miklušová M; Fürst T; Zimek D; Mareš J
    Mult Scler Relat Disord; 2024 Feb; 82():105402. PubMed ID: 38160638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Immunoenzymatic determination of free immunoglobulin light chains in the cerebrospinal fluid: its value in the biological diagnosis of multiple sclerosis].
    Allal C; Ghaffor M; Rabhi H; Chaouche M; Tazir M; Abbadi MC
    Arch Inst Pasteur Alger; 1989; 57():111-24. PubMed ID: 2518740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantification of immunoglobulin free light chains in cerebrospinal fluid by nephelometry.
    Desplat-Jégo S; Feuillet L; Pelletier J; Bernard D; Chérif AA; Boucraut J
    J Clin Immunol; 2005 Jul; 25(4):338-45. PubMed ID: 16133990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cerebrospinal fluid neurofilament light chains and CXCL13 as predictive factors for clinical course of multiple sclerosis.
    Hradilek P; Revendova KZ; Horakova J; Bunganic R; Pelisek O; Zeman D; Hanzlikova P; Kusnierova P
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2023 Mar; 167(1):30-35. PubMed ID: 36695545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Routine CSF parameters as predictors of disease course in multiple sclerosis: an MSBase cohort study.
    Dekeyser C; Hautekeete M; Cambron M; Van Pesch V; Patti F; Kuhle J; Khoury S; Lechner Scott J; Gerlach O; Lugaresi A; Maimone D; Surcinelli A; Grammond P; Kalincik T; Habek M; Willekens B; Macdonell R; Lalive P; Csepany T; Butzkueven H; Boz C; Tomassini V; Foschi M; Sánchez-Menoyo JL; Altintas A; Mrabet S; Iuliano G; Sa MJ; Alroughani R; Karabudak R; Aguera-Morales E; Gray O; de Gans K; van der Walt A; McCombe PA; Deri N; Garber J; Al-Asmi A; Skibina O; Duquette P; Cartechini E; Spitaleri D; Gouider R; Soysal A; Van Hijfte L; Slee M; Amato MP; Buzzard K; Laureys G
    J Neurol Neurosurg Psychiatry; 2024 Oct; 95(11):1021-1031. PubMed ID: 38569872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerebrospinal fluid and urinary biomarkers in multiple sclerosis.
    Dobson R; Topping J; Davis A; Thompson E; Giovannoni G
    Acta Neurol Scand; 2013 Nov; 128(5):321-7. PubMed ID: 23465040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.